SynthesisOncotarget2017

Does dual HER-2 blockade treatment increase the risk of severe toxicities of special interests in breast cancer patients: A meta-analysis of randomized controlled trials.

Shuai Hao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.